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Summary 
An increasing amount of evidence has shown that epitopes restricted to MHC class I molecules 
and recognized by CTL need not be encoded in a primary open reading frame (OR.F). Such 
epitopes have been  demonstrated  after stop  codons,  in  alternative reading frames  (RF)  and 
within introns. We have used a series of frameshifts (FS) introduced into the Influenza A/PR/ 
8/34 nucleoprotein (NP) gene to confirm the previous in vitro observations of cryptic epitope 
expression, and show that they are sufficiently expressed to prime immune responses in vivo. 
This presentation is not due to sub-dominant epitopes, transcription from cryptic promoters 
beyond the point of the FS, or internal initiation of translation. By introducing additional mu- 
tations to the construct exhibiting the most potent presentation, we have identified initiation 
codon readthrough (termed scanthrough here, where the scanning ribosome bypasses the con- 
ventional initiation codon, initiating translation further downstream) as the likely mechanism 
of epitope production. Further nmtational analysis demonstrated that, while it should operate 
during the expression of wild-type (WT) protein, scanthrough does not provide a major source 
of processing substrate in our system. These findings suggest (i) that the full array of self- and 
pathogen-derived epitopes available  during thymic selection and infection has  not been fully 
appreciated and (it) that cryptic epitope expression should be considered when the specificity of 
a CTL response cannot be identified or in therapeutic situations when conventional CTL tar- 
gets  are limited, as may be the case with latent viral infections and transformed cells.  Finally, 
initiation codon readthrough provides a plausible explanation for the presentation of exocytic 
proteins by MHC class I molecules. 
C 
D8+cytotoxic lymphocytes (CTL) recognize and re- 
spond  to  the  products  of protein  degradation  (epi- 
topes)  associated with MHC  class I  molecules at  the  cell 
surface (1-5).  It has been generally assumed that degrada- 
tion of full-length protein supplies the majority of epitope 
for  antigen  presentation.  However,  there  are  many  in- 
stances  reported  in  the  literature  describing  presentation 
from gene fragments and mini-genes that encode only the 
epitope (6-8), implying that full-length protein is not a re- 
quirement for efficient antigen presentation to CTL. More 
surprisingly,  evidence  exists  that  questions  the  basic  as- 
sumption  that  epitopes  must  to  be  encoded  in  primary 
open reading frames. Examples include the presentation of 
epitopes that follow stop codons (9),  are encoded in alter- 
nate  translation  reading  frames  (10-13),  are  presented in 
the  absence  of any obvious initiation  codons  (14)  or are 
even processed and presented in the apparent absence of a 
related  promoter  (15).  Explanations  that  have  been  pro- 
posed to account for these unusual  circumstances include 
ribosomal frameshifting (11,  13), alternative translation ini- 
tiation  codons  (14)  and  the  possibility  of subgenic  tran- 
scription events (the pepton hypothesis;  16).  However, in 
most cases the underlying mechanism(s) have not been elu- 
cidated. 
Until recently, cryptic epitope expression had remained 
an in vitro phenomenon. The immunological significance 
of unconventionally produced epitopes has now been dem- 
onstrated. An immunogenic human melanoma epitope has 
been mapped to a region of a novel gene encoded partially 
by exon 2 and the following intron (17), implying that the 
epitope is  expressed only when  imprecise splicing  events 
occur. The mutation that elicits  the  CTL response is  en- 
coded in the intron,  outside of the primary open reading 
frame  (ORF) ~.  Wang  et  al.  have  mapped  responses  of a 
melanoma-specific CTL line to a peptide encoded within 
an alternate reading frame of the gp75 gene (12). An earlier 
study by Uenaka et al.  (18),  in which a murine leukemia- 
specific epitope was mapped to the  5'  untranslated region 
of the gene, suggests  that alternative translation mechanism 
may also provide cryptic epitopes in vivo. In a more con- 
1Abbreviations used in this paper: BFA, brefeldin  A; FS, frameshift;  NP, nu- 
cleoprotein; OR.F, open reading frame; P,F, reading frame; UTR, un- 
translated region;  vac, vaccinia  virus; WT, wild-type. 
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prime  mice  to  an  epitope  shifted  to  an  alternate  reading 
frame by a single base deletion (13). 
The  potential  for  unconventional  epitopes  to  be  en- 
coded in  alternative reading frames  (RF)  and  untranslated 
regions  (UTR)  requires  that  the  whole  mP-.NA,  not just 
the primary RF,  be considered for examination when  de- 
termining possible substrates for efficient antigen processing 
and presentation.  In  addition to  providing a  new  array of 
epitopes, these mechanisms could provide a source of con- 
ventional R.F substrate that is, by virtue  of its abbreviated 
form,  more  efficiently processed  and  presented  than  full- 
length  proteins.  For both  in-frame  and  out-of-frame  epi- 
topes this may be more common than generally imagined. 
Additionally, epitopes in  alternate  reading frames  may  be 
important  contributors  to  immune  responses  in  vivo,  in- 
volved in  the  activation  of autoimmune  disorders and  of 
benefit in targeting CTL responses in cancer immunotherapy. 
Several  potential  explanations  for  the  production  of 
cryptic  epitopes  are  available for  consideration,  including 
many at the level of translation. The inherent flexibility of 
the  scanning  and  translating ribosome  has  produced  vari- 
ants  of conventional translation  (19)  that  could provide  a 
basis for cryptic epitope expression, including: (0 initiation 
codon scanthrough  (where the scanning ribosome bypasses 
the  5'  AUG  and initiates at an AUG further downstream; 
references 20-22);  (i  0  reinitiation of translation (where a ri- 
bosome  that has  terminated translation does not  dissociate 
from  the  message  and  begins  translation at  a  downstream 
AUG  codon  (22-24);  (iiO  ribosomal  frameshifting  (the 
scanning ribosome changes RFs in mid-translation, a  pro- 
cess greatly enhanced by the presence  of a  "slippery site", 
upon  which  the  ribosome  shifts  and  a  "pseudo-knot", 
which  causes  the  ribosome to  pause  over the  slippery site 
(25, 26);  (iv)  translation termination readthrough  (the con- 
text of the stop codon is insufficient to cause 100% of trans- 
lating ribosomes  to  terminate;  references  27,  28);  and  (v) 
internal initiation of translation (an internal ribosome entry 
site provides a "landing pad" for ribosomes to initiate trans- 
lation from internal AUGs; references 29-31). 
To  elucidate the  mechanism  and  gauge the  potential of 
cryptic epitope production, we have imposed a series of con- 
trolled genetic changes upon the influenza A  PR./8/34  nu- 
cleoprotein (NP) gene, predicted to prevent the translation 
of some  or  all  of three  well-defined  and  broadly  spaced 
MHC  class I-restricted epitopes.  These  manipulations not 
only  confirmed  the  possibility of cryptic  epitope  expres- 
sion,  but  further  demonstrated  in  vitro  and  in  vivo  that 
cryptic translation is a  physiologically relevant and  an  im- 
munologically  important  mechanism  for  supplying  sub- 
strate to the MHC  class I  antigen processing and presenta- 
tion pathway. 
Materials  and Methods 
Chemicals.  General  chemical  supplies  were  obtained  from 
Sigma Chem.  Co.  (St. Louis, MO).  Molecular biology reagents 
were obtained from New England Biolabs (Beverly, MA), except 
where noted. 
Animals.  6-8-wk-old female  inbred  CBA  (H2-k),  BALB/c 
(H2-d)  and  C57B1/6  (H2-b)  strain  mice  were  obtained  from 
Taconic  (Albany, NY)  or Jackson  Labs  (Bar Harbor,  ME)  and 
maintained in Thomas Jefferson University Animal Facilities. 
Tissue Culture.  L929  (H-2Kk),  L-Kd  (H2-K  k,  H2-K~;  L929 
transfected  with  H2-Kd;  reference  32),  and  MC57G  (H2-D  t') 
cells were grown in DMEM supplemented with 5% FCS (Sigma), 
37~  CO> 
Molecular Mallipulations.  All enzymes used for the manipula- 
tion of the NP gene were used according to manufacturers direc- 
tions. PCP-. primers and oligonucleotide linkers were synthesized 
by Kimmel Cancer Institute Nucleic Acid Facility. NP contain- 
ing a silent ApaI site in the H2-K  a (bp457-463)  epitope has been 
described elsewhere (8).  PCR.  directed mutagenesis was  used to 
incorporate a silent AatlI site in the H2-K  k epitope (bp165-171): 
GAG GGA CGT CTG ATC. These altered sites were then used 
in additional cloning of the NP gene. Most manipulations were 
done using a Bluescript  II SK +/-  vector (Stratagene Inc., La Jolla) 
with NP inserted in the EcoR.l site into the multiple cloning site. 
A similar strategy was used to insert an NheI site into NP3f,~,_374. 
Frameshifts.  Frameshift A  (FS-A) was  created by encoding a 
dropped base 5(C) and a Sail site in a 5' primer annealing to the 
5'  end  of NP  (TCG  CAG TCG  ACA TCA AAA TCA TGG 
GTC CCA A). A 3' reverse primer encompassing the AatlI site at 
bp165-171  allowed the production of a fragment for ligation, af- 
ter digesting with Sail and Aatll, into NP-Bluescript cut with Sail 
and AatlI. This was then shuttled into pSC11  (8) via the SalI and 
Notl  restriction  sites  for  vaccinia  (vac)  recombination.  FSs  B 
through E were created by cutting NP with AatIl, Narl, ApaI, or 
AvrlI restriction enzymes, respectively. The resulting digests were 
then incubated with DNA polymerase Large Fragment (Klenow 
fragment)  and  then  religated  (T4  DNA  ligase;  GIBCO  BRL, 
Gaithersburg,  MD).  Ligation reactions  were  used  to  transtbrm 
competent DH5ot E. coil Transformants were screened for loss of 
the restriction site and then sequenced to confirm the nmtation. 
Mutant NP fragments were then cloned into pSC11. 
Substitutious.  Due to the location of the ATG codons that we 
wished to ablate, two-step primer directed PCR nmtagenesis was 
used. A PCP,. primer pair encoding an ATG to ATC substitution 
and the appropriate surrounding sequence were used in indepen- 
dent reactions with the 5' primer pairing with an NP-specific 3' 
primer, and the 3' primer pairing with an NP-specific 5' primer. 
FS-A DNA was used as the template. The products of the inde- 
pendent PCR.s were gel purified to remove any surplus primers. 
The PCP, products were then mixed and allowed to anneal and 
extend in the absence of primers for three rounds ofa PCIZ. The 
flanking distal primers used in the first reaction were then added 
for the remaining cycles. The resultant extended PCI% encoding 
the mutations, was  ethanol precipitated and subject to restriction 
digestion for ligation into FS-A. 
Epitope Knockouts.  PCR  primers encoding substitutions  of the 
anchor residues were  used to  direct elimination of the  H2-K  k, 
H2-K  d, and H2-D  b epitopes. TTG GAT CAG ACG TCC CTC 
ATA AGT ACT encodes a D51T  substitution and  a silent Scal 
reporter site.  AAC  AAG  GCC  CCT  CGT  ACG  CTG  TGC 
AGT TGC  encodes a  Yt48A  and  a silent BsiW1  reporter site. 
These two oligos were used for 3' priming PCIZs with 5' primers 
spanning the SalI site at the front of the gene.  GTT CAA ATT 
GCT AGC AAT GAA GCT ATG encodes a 5'  primer with a 
N370A  substitution and a  silent Nhel  site. This was  used for a 
PCP,. reaction, paired with a vector derived 3' primer, to create 
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NP/M32IMutant.  Complementary oligonucleotides direct- 
ing an ATG to  ATC mutation (GTC  GGA AAA ATC ATT 
GGT and ACC AAT GAT TTT TCC GAC) were  used in a 
two-step PCR reaction, in combination with primers annealing 
to the region encompasing the Sail site preceding the gene and 
the engineered ApaI  site within the  NP/147-155  epitope. The 
PCR product was trimmed with Sail and ApaI and then used to 
replace the wild-type sequence between Sail and ApaI. 
Thermostable Duplex Barrier.  The first stage of the barrier was 
created  using a 5' PCR primer encoding the left hand side of the 
barrier,  the KpnI loop and an XbaI cloning site. This was used in 
conjunction with a SalI containing 3' primer, that anneals to the 
front of the NP  gene, to produce a fragment that inserted be- 
tween the XbaI and SalI sites in NP-Bluescript. The second stage 
5' primer encoded the KpnI loop at the 5'  end, the right hand 
side  of the barrier and a 3'  SalI site.  In conjunction with a 3' 
primer that anneals  to  internal NP  sequence, a PCR  fragment 
was produced that formed the duplex when inserted at the KpnI 
site of the first fragment (using an internal NP AatlI site as the 
other restriction point). The completed duplex barrier-NP frag- 
ment was cloned into pSC11  by digestion at the XhoI and NotI 
restriction sites, taking advantage of the cohesive end compatibil- 
ity between Sall and Xhol. Primer sequences were (0 first stage: 
ACG  CTC  GAG  GGG  GCG  CGT  GGT  GGC  GGGGTA 
CCA CGC GTC GAC GGT ATC GCG ATA AG and (i  0 sec- 
ond stage: CGG GGT ACCCCG CCA CCA CGC GCC CCG 
CTC GAC CAC CAT GGT GTC. 
Immunoprecipitations.  1 ￿  106 L-Kd cells were infected at  10 
PFU/cell. After 6 h incubation at 37~  in DMEM with 40 IxM 
LLnL  proteasome  inhibitor (a  kind gift  from  Dr.  Ken Rock, 
Dana-Farber Cancer Institute), the cells were starved for 30 min 
with Met/Cys-free DMEM (Biofluids Inc., Rockville, MD), fol- 
lowed by  a  45-min pulse  with  60  jxCi  35S  Met-Cys/106  cells 
(Amersham Corp., Arlington Heights, IL). Cells were lysed in the 
presence of 2 mM PMSF (Sigma) and an inhibitor cocktail  con- 
sisting of 0.2 mM AEBSF,  1 mM EDTA, 20 IxM Leupeptin and 
1 mM Pepstatin (Calbiochem-Novabiochem, San Diego, CA) and 
nuclei removed by pelleting at 12,000 g. The resulting superna- 
tants were precleared  for 12 h  at 4~  with protein A-Sepharose 
beads,  then incubated with rotation for 3 h at 4~  with protein 
A-Sepharose beads  to which the  NP-specific monoclonal anti- 
bodies H19S24  (a  gift  from Dr.  W.  Gerhard,  Wistar Institute, 
Philadelphia,  PA) and HB65 (American Type Culture Collection 
[ATCC], Rockville, MA) had been bound. The beads were then 
washed four times and boiled in reducing buffer before separation 
on a 10% SDS-PAGE. 
Viruses.  Vaccinia recombinants were made as previously de- 
scribed (8). Briefly all altered genes were ligated between the Sail 
and NotI sites in modified pSC11  for expression  from the P7.s 
promoter. These plasmids were then introduced into the vaccinia 
genome via homologous recombination in CV-1 cells (CCL 70; 
ATTC) and plaque purified in 143B HuTK- (CRL 8303; ATTC) 
cells in the presence ofBrdU (Boehringer Mannheim, Indianapo- 
lis, IN).  In all cases the integrity of the recombinant was deter- 
mined by isolating vac DNA and sequencing after PCR amplifi- 
cation of the mutant gene. Additionally, viral expression products 
were  analyzed  by  northern blotting to  confirm mRNA  size. 
Control vac used in the experiments were generated by recom- 
bining the pSC11  plasmid with no insert into the vac genome. 
CTL Assay.  APC were infected for 1 h at 37~  with vaccinia 
recombinants at 10 PFU/cell at a concentration of 107 cells/ml in 
balanced salt solution containing 0.1% BSA.  After  1 h, 10 ml of 
preconditioned (37~  9% CO2) DMEM  +  5% FCS was added 
and the  cells incubated a further 3 h  with rotation. Cells were 
pelleted and resuspended with 50  /,1/  106 cells of IMDM with 
7.5% FCS containing 100 /*Ci of NaSlCrO4  (Amersham  Corp.) 
and incubated for  1 h  at  37~  APC  were  then washed  three 
times with DPBS and resuspended in IMDM and combined with 
CTL populations in round-bottom plates at 104 cells/well.  APCs 
and CTL were coincubated for 4 h at 37~  before 100/~1 ofsu- 
pernatants  were  collected  and  counted  in  a  gamma  detector 
(Wallac, Turku, Finland). The data are presented as percent spe- 
cific SlCr, defined as  100  ￿  ([experimental  cpm -  spontaneous 
cpm]/[total cpm -  spontaneous cpm]).  In some assays Brefeldin 
A  (BFA) was  added  to  a  final  concentration of 5  Ixg/ml and 
maintained at that concentration until harvest of supernatants. 
Generation of CTL.  CTL restricted to H2-K  k, H2-K  a, or H2-D  b 
were  derived  from NP immunized CBA, BALB/c or C57BL/6 
mice, respectively,  as described  elsewhere  (33). Mice were  im- 
munized by intraperitoneal injection of 10  v PFU of NP-vac. Af- 
ter at least 2 wk, spleens from appropriate  mice were harvested 
and one-third of cells infected with PR8 for restimulation. Sec- 
ondary cultures  were incubated at 37~  CO2 for 6-7 d be- 
fore  harvesting for effector populations. For in vivo priming as- 
says, duplicate  mice were injected intraperitoneal with 4  ￿  106 
PFU of each  recombinant vac and left for 2 wk before spleno- 
cytes were restimulated in vitro with PR8 or wild-type vaccinia 
vires. 
Results 
Construction  of Out-of-Frame  Epitopes  in  Influenza  Nudeo- 
protein.  To pursue studies on the contribution of epitopes 
encoded in alternate reading frames to MHC class I-medi- 
ated immune responses, we introduced a series of FSs  (de- 
picted in Fig. 1) into the NP gene. NP contains three well- 
defined MHC class I epitopes, which encompass amino acids 
50-57 (NP50_s7: H2-K  k restricted), 147-155 (NP147_IS5: H2-K  d 
restricted), and 366-374 (NP366_374: H2-D  b restricted)  (34- 
37). The FS series is predicted to have diverse effects on the 
production of the  three  epitopes.  For example, frameshift 
A  (FS-A)  is  a  shift  into  the  + 1  RF  (where  the  primary 
ORF is defined as RF0) at the second codon. This is pre- 
dicted to cause termination at codon 16, which would lead 
to no epitope production by conventional  translation. Even 
if all termination codons in the  + 1 RF were to be ignored 
by the  translating ribosome, translation of the regions en- 
coding the three epitopes will produce nothing resembling 
NPso_s7, NP147_lSS, or  NP366_374, as  shown in Fig.  1.  The 
frameshifted mutant NP  genes were  recombined into the 
vaccinia virus (vac)  genome and the resultant viruses were 
checked for fidelity by PCR amplification and sequencing 
of the altered gene. Immunofluoresence  staining of cells in- 
fected with the  vac  recombinants, using an antibody that 
precipitates NPlqs8 (HB-65), yielded no specific signal and 
initial NP-immunoprecipitations from  cells  infected with 
the vac recombinants, using monoclonal antibodies having 
complementary specificities, did not yield any specific bands 
(data not shown). 
Presentation of Out-of-frame Epitopes In  Vitro.  Several stud- 
ies have demonstrated expression of epitopes despite their 
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Figure 1.  Positioning of the NP frameshifr mutations and the predicted 
impact upon NP translation with respect to three MHC class 1 epitopes. 
These ffameshifts have the effect of moving the NPs. s7, NPt47-15> and 
NP.v,. 374 epitopes into alternate reading flames. The nature of the ffante- 
shift, their position and their predicted translation termination points are 
shown.  The  predicted  eft)ct  on  translation  in  the  region  where  each 
epitope  sequence is  encoded  (if the upstream termination codon  is ig- 
nored) is depicted. 
having been  shifted  out  of the  conventional  RF  (10,  11, 
13,  14).  To  determine whether this was  true  for our con- 
structs using the vac expression system, each was tested for 
presentation of all three NP  epitopes. Cells expressing the 
H2-K  k, H2-K  a, or H2-D b MHC  class I molecules were in- 
fected with  the vaccinia recombinants and incubated with 
secondary culture CTL derived from CBA (H-2k), BALB/c 
(H-2d), and  C57B1/6  (H-2 b) mice immunized to NP.  Be- 
cause  the location of the  FSs and  the  consequential  effect 
on NP translation, presentation would be predicted to dif- 
fer  for  each  construct.  FS-A:  (a  shift  into  the  +l  1KF  at 
codon  2,  predicted to  terminate  at  codon  33)  is not pre- 
dicted to present any  of the  epitopes, although  a previous 
study with a similar mutant  (10)  showed retained presenta- 
tion of NPs0_57 and NP147_155. Our results confirm and ex- 
tend those findings, in that all three epitopes are presented 
in the face of FS-A. Frameshift B  (FS-B: a shift to the  -1 
frame  at  codon  55  (actually within  the  NPs0_s7 epitope), 
predicted to terminate at codon 70) is also predicted to pre- 
vent presentation of all three epitopes. When assayed, pre- 
sentation of NPs,_.w  and NP147_lS  5 are indeed ablated, while 
NP366_374  is  surprisingly  still  capable  of sensitizing  target 
cells to CTL-mediated lysis. Frameshift C  (I=S-C: a shift to 
the  +1  frame  at  codon  121,  terminating  at  codon  151) 
maintains presentation of NPs0_57 (as expected since the FS 
occurs after this epitope) but is unable to present NPHT_155. 
In contrast, NP3(,6_.w  4 is presented when expressed from this 
nmtant,  though  at  much  reduced levels in  comparison  to 
FS-A and  FS-B.  Frameshift  D  (FS-D:  a  shift  to  the  +1 
frame  at  codon  151,  terminating  at  codon  164)  presents 
partially as predicted,  with  NP50_s7 retaining presentation, 
NPHT_155 not  presented  (as  the  FS  is  within  this  epitope) 
and  NP3~,~,_374 presented  slightly  above  control  vac.  This 
very low level of presentation was consistently observed in 
many independent assays. Frameshift E  (FS-E: directs a shift 
to the -1  frame at codon 175, temainating at codon 201) is 
CBA (H-2  k)  BALB/c (H-2  d)  C57B1/6 (H-2  b) 
80  4O 
~40 
*.  FS-E 
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Figure 2.  In vitro presentation of NP frameshift recombinants. APC 
expressing H2-K k (L-Kd), H2-K  d (g-Kd), or H2-D  u (MC57G) were in- 
fected for 4 h with vaccinia recombinants before SlCr labeling and incu- 
bation with  NP-specific CTL  generated by priming with  NP vac and 
restimulating in vitro with PP,.8 as described in Materials and Methods. 
NP-Vac and FS-A are presented to all haplotypes, WT control vac is pre- 
sented on none and FS-B, FS-C, FS-D, and FS-E are presented at differ- 
ent degrees to each haplotype. Vac restimulated splenocytes were used to 
confirm equal infection of target APCs (data not shown). 
the  only construct  that  performs  completely as  predicted, 
maintaining  presentation  of NP~_s7  and  NPI47_15  ~  while 
losing  any  presentation  of NP3(,(,_374 (Fig.  2).  It  is  espe- 
cially noteworthy  that  presentation  of the  H2-D b epitope 
(NP3(,¢,_374) is proportional to  the  distance of the  FS event 
from the 5' end of the gene. This conforms to Kozak's pre- 
dictions for ribosomal reinitiation potential, in that the fur- 
ther the termination event is from the 5' cap, the less likely 
reinitiation is to occur (38). 
h~  Vivo Presentation of CrTptic Epitopes.  Aside from a re- 
cent  publication  (13),  demonstration  of  alternative  RF 
cryptic epitope presentation has been  restricted to in vitro 
observations. Having established in our system that mecha- 
nisms exist that can overcome the effect of the FSs and en- 
able translation at levels that  are  sufficient to  sensitize the 
infected presenting cells in  vitro,  we  wished  to  assess  the 
ability of these  epitopes to be presented in vivo. C57B1/6 
(H-2  b)  mice  were  inoculated  with  recombinant  vac  ex- 
pressing FS-A, FS-B, FS-C, FS-E, NP-vac, or control vac. 
After 2  wk,  their spleens were  used to  1hake in vitro sec- 
ondary  cultures  by  restinmlation  with  P1K8.  To  confirm 
equal  priming,  a  fraction  of the  splenocytes was  restinm- 
lated with wild-type (WT) vac (Fig. 3, sub-graphs). Each of 
the CTL populations was tested in standard chromium re- 
lease assays for specific lysis of cells infected with WT  NP, 
presenting the NP366_374 epitope. The  data in  Fig.  3  show 
that, in addition to CTL from NP-primed mice, CTL de- 
rived from mice primed with FS-A and FS-B were capable 
of specifically lysing cells expressing WT  NP.  In  contrast, 
FS-C  and  -E  did  not  produce  any  significant  priming. 
Therefore it is likely that the same mechanisms that are re- 
sponsible for the production of cryptic epitopes in this sce- 
nario  are  available to  the  mmmne  system  during  natural 
imnmne responses. It should be noted, however, that cryp- 
tic epitope expression in our system appears to be stronger 
when  analyzed in vitro,  compared to  in vivo.  Only FS-A 
and  FS-B constructs were  capable of printing responses to 
NP in vivo (with FS-B priming much poorer), while FS-A 
to FS-D were all detected in vitro. 
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Figure  3.  In vivo immunogenicity of alternative  ILF epitopes.  Dupli- 
cate C57B1/6 mice were inoculated with recombinant  vaccinia expressing 
FS-A, FS-B, FS-C, or FS-E, control vac or NP-vac. Splenocytes derived 
from these mice were restimulated with PR8 (for NP366_374-specific CTL) 
or WT vac (for vac-specific controls).  After 6 d cultures were tested for 
the ability to lyse APCs infected  with NP-vac, control vac or left unin- 
fected. All constructs  were capable of eliciting vac-specific responses but 
only FS-A and FS-B elicited significant NP-specific  response& 
In  Vitro  Cryptic Epitope Presentation  Is Not Due to Subdom- 
inant Epitopes.  To  address  the  argument  that  antigen pre- 
sentation  observed from  the  expression  of these  constructs 
is due to subdominant  epitopes, we created a series of con- 
structs  that  should  eliminate  presentation  of the  described 
epitopes.  This  is  of particular  concern  for  the  NP366_374 
epitope as an observation by Oukka  et al.  (39)  showed that 
an  additional  H2-D b epitope  exists at  NP55_63.  In their sys- 
tem  this  epitope  was  shown  to  be  produced  at  levels that 
are toleragenic, although this might not be true in a recom- 
binant  vac  expression  system.  Three  separate  NP  mutants 
were constructed  in which one of the dominant MHC  class 
I binding anchor residues was substituted  with a non-anchor 
amino  acid  for  each  of  three  epitopes:  the  substitutions 
were D51--+T51  (D51T,  H2-Kk), Y148--+A148  (Y148A,  H2-K  d) 
and  D370--+A370  (D370A,  H2-Db),  respectively,  changes 
that are predicted to abrogate the binding of the epitope to 
the restriction  element.  (40).  Fig.  4  shows  that  eliminating 
the respective anchor residue ofNPl47_155 and NP366_374  ab- 
lates presentation,  while presentation  of NPs0_57  is severely 
curtailed.  In  each  case,  expression  and  presentation  of the 
unmutated  epitopes were not affected.  The  in vivo response 
by  H-2b  mice  to  FS-A could  also  be  ascribed  to  recogni- 
tion  of NP366_374; spleen  cells from  C57B1/6  mice  primed 
with  FS-A and  restimulated  with  PR8  did  not  respond  to 
the D370A mutant  (data not shown).  These data imply that 
the presentation that is observed with the frameshifted con- 
structs  is  due  to  the  translation  of the  dominant  epitopes 
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Figure  4.  Subdominant  epitopes  do not account  for the vast majority 
of presentation  from the frameshifted  constructs.  Anchor residues from 
each  of the  three  epitopes,  NPs0s7 (D51T),  NP147_15  s  (Y148A), and 
NP366_374 (D370A) were mutated  to ablate MHC class I binding,  thus al- 
lowing  any  subdominant  epitopes  to  be  presented.  Vac  recombinants 
were assayed in standard  SlCr release assays with respect  to control-vac 
and NP-Vac. 
50-57  (H2-Kk),  147-155  (H2-K  d)  and  366-374  (H2-Db), 
although  some  NP-specific  presentation  from  the  D51T 
mutant  is occurring.  This may be due either to the expres- 
sion of a very minor sub-dominant  epitope or some persis- 
tent binding  and  CTL  antigenicity on  the part  of the mu- 
tated  epitope.  Pertaining  to this,  we have noticed in many 
of our studies that NP50_57 is a highly immunogenic epitope, 
capable ofeliciting very strong immune responses  (Bullock, 
T.NJ.,  and L.C. Eisenlohr,  unpublished  observations). 
In  Vitro Presentation  of Out-of-Frame Epitopes Is Not Due to 
Cryptic  Promoter  Activity  or  Internal  Initiation  of Translation. 
Several alternative  explanations,  aside from cryptic  transla- 
tion,  could account  for the presentation  of the out-of-frame 
epitopes  from  cells  infected  with  the  vac  recombinants. 
The  expression  of out-of-frame  epitopes that  we  have  ob- 
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Figure  5.  Limited  influence  of cryptic vac promoters  and sites for in- 
ternal  initiation  of translation  in  expression  of the NP gene.  A thermo- 
stable duplex  barrier  was inserted  in front of the NP gene to block the 
progress  of scanning  ribosomes  (A). Such  a barrier  would be  circum- 
vented by vac promoters  that exist in the NP gene. When assayed to test 
for the ability to sensitize APCs for CTL activity (B), presentation  of all 
three  epitopes from the stem-loop containing  gene was severely reduced 
in comparison to NP-vac, though not quite to the level of control vac for 
NPso_s7 and  NP3~6_374. Vac-specific  killing  was  unaffected  (data not 
shown). 
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of frameshif~ed mutants of NP 
expressed from vaccinia recom- 
binants. Cells were infected with 
the  indicated  vac  recombinants 
for 6 h at 37~  in the presence of 
the proteasome inhibitor LLnL and were pulse labeled for 45 min with 
3sS  Met/Cys.  Cells were lysed, pre-cleared and immunoprecipitations 
were carried out using NP-specific antibodies in the presence of protease 
inhibitors. Lane 1, control vac; lane 2, NP-vac; lanes 3-7, FS-A to -E; 
lane 8, NPI47 *vs. Arrow denotes the NP-specific FS-A product. 
served  could  have  been  due  to  cryptic  vac  promoters 
within  the  NP  gene.  These  could be located downstream 
of the  FS mutations and allow conventional translation of 
the primary ORF  from RF  0.  This is a potential explana- 
tion for the behavior of FS-B and FS-C (lack of presenta- 
tion of NP147_ts  s but presentation of NP366_374). To  address 
this  possibility, we  inserted  a  thermostable  duplex  barrier 
between the P7.5 vac promoter and codon 1 of NP (Fig. 5 a). 
Such a barrier is predicted to block the progression of a ri- 
bosome scanning from the 5' end of the NP gene, as previ- 
ously demonstrated by Kozak using a similar structure (20). 
Indeed we were not able to immunoprecipitate any specific 
product expressed from this construct  (data not shown).  If 
presentation is dependent upon the ribosome scanning un- 
impeded from the 5'-cap to AUG1, then expression of the 
three epitopes in NP would be ablated. However, if cryptic 
vac promoters exist within the NP gene, the barrier would 
not be incorporated into the mRNA  and translation of the 
epitopes should be unhindered. The data shown in Fig. 5  b 
demonstrate that there is a drastic reduction of presentation 
of all three  epitopes.  The  remaining presentation seen  for 
NPso_s7  and  NP366_374 could  be  due  to  some  cryptic  vac 
promoter activity at a  level that  can be detected by CTL. 
However, the graded presentation of NP366_374 with respect 
to the FS series argues against this possibility. The retained 
presentation  may in  fact be  due  to  a  biochemically unde- 
tectable  amount  of leakiness  in  the  duplex  barrier.  Cer- 
tainly,  the  level  of epitope  expressed  from  this  construct 
cannot  account  for  the  majority of NPso_s7  and  NP3r  374 
presentation seen with FS-A and FS-B. As more fully dis- 
cussed below, we believe that NP147_l~  5 is not an efficiently 
presented  epitope.  This  is  a  feasible explanation for  these 
results and others (Figs. 2  and 7)  in  which presentation of 
NPs0_sv and NP366_374 persists while that of NP147_  155 is lost. 
This  result also makes it very unlikely that  internal initia- 
tion  of translation  is  responsible  for  significant  levels  of 
cryptic epitope production,  as this  mechanism  would  also 
allow  bypass  of the  thermostable  duplex  and  translation 
from an internal entry site. 
Immunoprecipitation of Frameshifted Constructs.  Results  de- 
scribed thus far suggested that bypass of the frameshift mu- 
tations occurs in our system at the level of translation. Ini- 
tial  screens  using  a  cocktail  of  NP-specific  mAbs  only 
immunoprecipitated NP  from  NP-vac-infected cells  (data 
not  shown).  However,  the  products  from  cryptic transla- 
tion are likely to be produced at low levels and may be in- 
herently unstable. Therefore we repeated the screens in the 
presence  of the  proteasome  inhibitor  LLnL  and  the  in- 
fected, pulsed ceils were lysed in the presence of a protease 
inhibitor  cocktail  consisting  of AEBSF  (serine  proteases), 
EDTA (metalloproteases), leupeptin (broad range), and pep- 
statin (acid proteases). As can be seen from Fig. 6, the antibody 
cocktail was  capable  of immunoprecipitating NP  (lane  2) 
and a fragment consisting of NP147_498 (lane 8). Under these 
conditions  a  band  with  molecular weight  slightly smaller 
than NP was precipitated from FS-A-infected cells (lane 3). 
No specific bands were precipitated from lysates of cells in- 
fected with FS-B, FS-C, FS-D, or FS-E. 
Ribosomal  Scanthrough to  the AUG32  Codon Appears  to Be 
the Mechanism Responsible  for Presentation of FS-A.  The  im- 
munoprecipitable smaller band from FS-A suggested initia- 
tion  at  an  internal  AUG,  either via reinitiation  (after en- 
countering a termination codon, in our case codon 33, the 
ribosome  then  proceeds  to  translate  from  a  downstream 
AUG)  or  scanthrough  (the  ribosome  bypasses  AUGI  in 
preference  of an  alternate  downstream  AUG,  e.g.,  codon 
13, 32, or 43). The shorter band also argues against an early 
natural frameshifting event by the ribosome as the product 
of this  mechanism  should  be  full-length.  To  discern  be- 
tween  these  possibilities,  we  eliminated  two  AUG  start 
codons from FS-A in separate constructs  (Fig. 7  a).  This was 
accomplished by primer directed mutagenesis,  substituting 
ATG to ATC at either codon 13 or codon 32 within FS-A, 
affecting  a  methionine  to  isoleucine  substitution  (termed 
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Figure 7.  Effect  of  AUG to AUC substitutions  on presentation of FS-A. 
(A) Positioning of potential conventional initiation (AUG) codons at the 
5' end of FS-A. To account for the method of out of frame epitope pro- 
duction from FS-A, AUG13 and AUG32 were serially  disrupted by substi- 
tution, thus making them unavailable for translation initiation. (B) M 131 
and M321 mutations were introduced  into  FS-A and recombined into 
vaccinia. The recombinants were assayed in standard S~Cr release assays 
with respect to WT-vac,  NP-vac and FS-A, with NP-specific bulk sple- 
nocyte secondary cultures. 
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FS-A/M13I,  or  FS-A/M32I,  respectively).  When  assayed 
in  standard  chromium  release  assays,  presentation  of FS-A 
was  little  affected by the  M13I  mutation  (Fig.  7  b).  How- 
ever,  the  FS-A/M32I  recombinant  had  virtually no  ability 
to  sensitize  cells  for CTL  lysis.  The  severity  of this  single 
mutation  on  presentation  was  quite  surprising  given  the 
persistence  of presentation  in  the  face of the  FS  mutations 
which  might  be  considered  to  be  much  more  severe  ma- 
nipulations  of the gene. As with our other recombinants  in 
this  work,  we  have  sequenced  the  relevant  region  of the 
vac genome  and  can  find no  changes  other  than  those  in- 
tended.  This  implies  that AUG32  is intrinsically  important 
in the translation  of epitope for antigen presentation of FS-A. 
As there is no translation termination codon in the  -1  read- 
ing  frame  (adopted  by  the  ribosome  after  the  FS)  until 
codon  33,  this  also  suggests  that  ribosomal  scanthrough, 
and  not  reinitiation,  is  responsible  for  the  production  of 
out-of-frame epitopes from FS-A. 
Initiation at AUG32 Does Not Provide a Major Source of Sub- 
strate in the Processing of Wild-type NP.  An attractive hypothe- 
sis  proposed  in  several  different  forms  is  that  products  of 
aberrant gene expression  are processed with particular  effi- 
ciency  due  to  their  immediate  targeting  for  degradation. 
With  this  concept  in  mind  we  tested  the  possibility  that 
initiation  at M32 is an important  event even in the process- 
ing of wild-type NP. We employed site-directed mutagen- 
esis  to alter the thirty second codon  of wild-type  NP from 
ATG  to  ATC,  effecting a  M--+I  change.  The  mutant  ap- 
peared to be identical  to WT  NP  in  terms of stability and 
nuclear  localization  (data  not  shown).  NP/M32I  was  also 
indistinguishable  from wild-type NP in the presentation  of 
NP147_155, the  epitope  that should  be most sensitive  to  any 
compromise in the level of processing substrate  (Fig.  8).  In 
this  assay,  target  cells  were  pulsed  with  control  virus,  NP 
vac,  and  NP/M32I  vac  and  then  exposed  to  brefeldin  A 
(BFA)  at various points post infection  for the remainder of 
the  assay. BFA blocks transport  of proteins  to  the  cell sur- 
face and can therefore be used as an indirect measure of the 
relative efficiency with which class I-peptide complexes are 
formed (41).  Under these conditions,  in which  time points 
associated with sub-maximal presentation  were clearly em- 
ployed,  the  kinetics  with  which  the  epitope  was  formed 
from  the  wild-type  and  mutant  proteins  are  essentially 
identical.  Thus,  scan-through  to AUG32 does not appear to 
provide  a  significant  source  of processing  substrate  during 
the  expression  of wild-type  NP.  This result was supported 
by performing  of a  similarly structured  assay in  which  the 
kinetics  of NP366_374 expression  from  wild-type  and  FS-A 
were compared (not shown).  The amount ofNP366_374 pro- 
duced by infection with  FS-A was significantly lower than 
that produced as a result of infection with WT  NP vac. 
Discussion 
In this  manuscript  we provide  evidence  confirming  and 
extending  previous  observations  by others  concerning  the 
processing and presentation  of cryptic epitopes  (9-14,  42). 
Our  in  vitro  presentation  data  concurs  with  the  results  of 
Fetten  et al.  and provides  the  additional  support  of a  third 
nucleoprotein  epitope,  NP366_374. In  comparison  to  all but 
one  preceding  study  (13),  we  have  used  the  recombinant 
vac expression system. For purposes of this study, this strat- 
egy offers several advantages over other expression systems. 
First,  vac has a  cytoplasmic replication  cycle and  therefore 
uncontrolled  genomic integration  and NP mRNA  splicing 
are  not  an  issue.  Second,  vac infects  a  wide  range  of cells 
which  allows us to study  the presentation  of multiple,  dif- 
ferentially  restricted  epitopes.  Vac is also  efficient at prim- 
ing  immune  responses,  permitting  us  to  assess  the  antige- 
nicity of cryptic epitopes in vivo (43,  44). 
The  study  of cryptic  epitope  expression  has  provided  a 
forum  for  the  debate  as  to  whether  CTL  are  sensitive  to 
very low levels of antigen production.  It has been proposed 
that antigen needs to be well expressed  (detectable by con- 
ventional biochemistry)  to elicit a CTL response  (10), while 
others  have  suggested  that  CTL  respond  to  vanishingly 
small  amounts  of epitope  (14).  Our  results  are  more  in 
agreement  with  the  latter  position.  Immunoprecipitable 
quantities  of FS-A  were  only  achieved  in  the  presence  of 
proteasomal  and  protease  inhibitors  and  we were  not  able 
to immunoprecipitate  any product from FS-B infected cells 
(Fig.  6).  Despite  this,  both FS-A and  FS-B  were well pre- 
sented  at  NP366_374. The  low  levels  of antigen  produced 
from  these  mutant  constructs  (FS-A  and  FS-B)  were  also 
sufficient  to  prime  NP-specific  immune  responses  in  vivo 
(Fig.  3),  confirming our in vitro results,  and providing evi- 
dence  that cryptic epitopes encoded in alternative  R.Fs can 
play a significant role in natural immune responses. An im- 
portant observation from these data is that not all of the FSs 
that  could  elicit  CTL  responses  in  vitro  were  capable  of 
priming  in  vivo.  This  suggests  that  there  is a  difference  in 
sensitivity levels between the two assay techniques  arid care 
should  be taken  when  assessing the  true  activity of cryptic 
epitopes in immune responses. 
Two  strategies  that  we  adopted  were  very  helpful  in 
eliminating potential  mechanisms  underlying the initial re- 
sults.  First,  point  mutations  at  anchor  residues  in  each  of 
the conventional  epitopes allowed us to ascribe virtually all 
of the bypass of the FS mutations  to expression of NP50_57, 
NP147_Iss,  and  NP36(,_374 and  not  emergent  subdominant 
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within the 5' UTR  of the NP gene indicated that the ma- 
jority  of epitope production  from the  NP  gene is  due  to 
translation proceeding from the 5'  end of the NP gene, as 
opposed  to  either  translation  from  abbreviated transcripts 
resultant from vac promoters within the NP gene, or from 
sites  of internal initiation  (Fig.  4).  The graded diminution 
in NP36{,_374  presentation as the FS became more distal (Fig. 2) 
also  argues  against  the  influence  of cryptic  vac  promoter 
with NP. Ifa cryptic promoter within the NP gene was re- 
sponsible  for  this  low  level  of NP36()_374 expression,  one 
would  expect an abrupt loss  of presentation with the  first 
FS downstream of the promoter. The low level of H-2  b re- 
activity associated with the duplex construct seems likely to 
be  due  to biochemically undetectable  leaking of scanning 
ribosomes through  the  thermostable duplex.  This level of 
leakiness  is  probably  not  sufficient  to  elicit  NP147_155 re- 
sponses,  however,  as  we  believe  NP14?_ls  s  is  inefficiently 
processed relative to NPs0_sv and NP366_374. This is perhaps 
due to a major proteasomal cleavage site within the epitope 
itself (Yellen-Shaw,  A.,  and L.C. Eisenlohr,  manuscript in 
preparation), which would explain why its expression is ab- 
sent with the duplex barrier in place. None of our manipu- 
lations completely ablated H-2  k reactivity and we believe it 
quite possible that there is a minor H-2  k -restricted epitope 
elsewhere in the NP gene. However, we do not think that 
this persistent low level of reactivity compromises our con- 
clusions. In those cases where we observed H-2k-restricted 
epitope  expression  relevant  to  the  central  theme  of this 
work (FS-A and FS-A/M13I), presentation levels were maxi- 
mal and therefore almost entirely attributable to expression 
of NPs0_5v. These findings, therefore, permitted us to focus 
our attention on mechanisms at the level of translation. 
Examination of our results with respect to the position- 
ing of the FSs suggest that at least two variants of conven- 
tional translation  account for cryptic epitope presentation. 
It is apparent from the introduction of ATG--+ATC substi- 
tutions  superimposed  upon  FS-A,  that  AUG32  is  nearly 
requisite for CTL responses to the products of FS-A. This 
nmtation  determined  that  scanthrough  was  the  probable 
mechanism at work for FS-A,  as there are no termination 
codons between the FS event and codon 32. By definition, 
ribosomal reinitiation is not responsible for epitope expres- 
sion from FS-A. The effect of the single point mutation on 
AUG32 initiated translation was startling in its severity con- 
sidering that the substitution at AUG13 had no effect on the 
presentation of any of the  epitopes under study (Fig.  7  b). 
Scanthrough  is not  a  vac-specific mechanism.  It has been 
directly observed in transfected yeast and mammalian cells 
(22-24)  and therefore should be possible under many con- 
ditions of gene expression. 
Although  we  have  shown  that  ribosomal  scanthrough 
can  successfully produce  cryptic  epitopes  when  initiating 
near the 5'-cap, a second mechanism seems likely to oper- 
ate for FS-B expression as the distance from the 5'-cap that 
scanthrough  can successfully operate appears limited.  This 
is seen in the failure of AUG6{, to compensate for the loss of 
AUG32 in producing substrate for epitope excision, despite 
the  excellent  context  surrounding  this  codon  (CCG- 
GAAUGG;  Kozak has  defined  good  initiation  context  as 
CC(A/G)-3CCA+IUGG  +4,  with  the  purine  at  -3  being 
in place 97% of the time and the guanine at  + 4 important 
in the absence of the -3  purine; reference 45). With this in 
mind,  it  is  most  likely  that  FS-B-expressed  epitopes  are 
produced by an alternate  method.  Reinitiation  of transla- 
tion seems a strong possibility. There are limitations to this 
mechanism with respect to both the length of the upstream 
ORF  (23)  and the  intercistronic  distance  (24,  46,  47),  but 
many possible FS-B reinitiation events are still permitted by 
these criteria. The fact that NP366_374  is presented from FS-B 
while NP]47qss  is not suggests that reinitiation  may occur 
downstream of NP147_ls  s. However, there are several other 
influencing factors with NP147_/ss, principally its inefficient 
expression even from WT NP  as mentioned above. A  re- 
maining question is why the FS-B expression mechanism is 
not available to FS-A/M32I. Theoretically, the AUG codon 
that  is  used for reinitiation  in  the  expression  of the  three 
epitopes from FS-B should still be available for FS-A/M321 
translation,  unless the positioning of the two conventional 
translation termination codons  (33  and 70,  respectively) is 
significant.  Experiments designed  to  elucidate  the  mecha- 
nism underlying the bypass of FS-B  are ongoing and may 
shed light on this question. 
Another demonstrated means of cryptic epitope expres- 
sion  is  the  initiation  of translation  at  non-AUG  codons 
(48).  These alternative codons include AUU, UGG, GAU, 
ACG,  CUG,  and GCG,  of which  the  latter three  are the 
more potent at initiation.  Recent studies have shown  that 
such  codons  are  capable  of driving  the  translation  of an 
epitope in  me absence  of a  conventional initiation  codon 
(14).  There  is  one  in-frame  alternative  initiation  codon 
(GAUl6) preceding AUG3,_ in NP and 2  (AUU33, AUU36  ) 
immediately following,  all  of which  are in  optimal initia- 
tion context. However, it is apparent from the effect of the 
AUG32  substitution  that  alternative  translation  initiation 
codons do not contribute  significantly to  epitope produc- 
tion  from FS-A  in  our  system,  although  this  might  have 
been  different if the  stronger alternative  initiation  codons 
had been available. 
As a natural extension of our in vivo results,  demonstrat- 
ing  the  strong  priming potential  of FS-A,  it  seems likely 
that ribosomal scanthrough of the primary initiation codon 
(AUGD could be occurring during the production of pro- 
teins in vivo. Therefore, it is quite possible that this transla- 
tion  mechanism is providing processing substrate from al- 
ternative RFs for many genes in the natural situation. This 
is  dependent  upon  the  portion  of  the  gene  that  scan- 
through  can use as a template, and whether this region of 
the  gene encodes an immunogenic epitope. Although  our 
data  suggest  that  scanthrough  is  limited  to  the  5'  end  of 
mRNA, the potency of this mechanism is demonstrated by 
the ribosome bypassing four AUG codons and one alterna- 
tive initiation codon before initiating translation at AUG32 
(Fig.  7  a).  The  scanthrough  initiation  is  at  a  strength  and 
1326  Presentation ofCTL Epitopes from Alternative Translation Reading Frames frequency that enabled us to immunoprecipitate a polypep- 
tide  smaller than  NP  from recombinant vac infected cells, 
using NP-specific antibodies  under the  appropriate condi- 
tions.  Furthermore, in a  more controlled setting,  we have 
confirmed the  ability of ribosomes to ignore the  5' initia- 
tion codon (even those with excellent context) and utilize a 
downstream initiation  codon in an alternative IKF to pro- 
duce sufficient epitope for CTL activation (T.N.J. Bullock 
and L.C. Eisenlohr, manuscript submitted). Encouraged by 
this result, we have tested the possibility of identifying nat- 
urally expressed epitopes eneoded in alternative IKFs with a 
computer based search of the uiral  protein database, target- 
ing  sequences  from  th~  alternative  translation  IKFs  con- 
forming to the HLA-A~I motif (38).  Numerous alternative 
OIKFs at the  5' end of the conventional ORF  conformed 
to our parameters and we are currently determining the in- 
fluence  of such  natural, cryptic  epitopes  in  immune  re- 
sponses. Why have such epitopes not been previously iden- 
tified? The most reasonable answer probably lies in the fact 
that  there  has  not been a  pressing need  to  identify them. 
Standard techniques for epitope detemfination focus on the 
primary O1KFs, with T  cell clones that do not map to these 
regions being discarded. The extra effort required to inves- 
tigate all three 1KFs would only be used in such prominent 
cases  as  tumor  antigens  or  alloantigens.  Recently,  Malar- 
kannan  et al.  (42)  reported on  an alloreactive epitope en- 
coded  in  an  alternative  translation  1KF. Overlapping pep- 
tides failed to identify the epitope and its nature eluded the 
authors  until  they expressed the  appropriate region in  the 
different  reading  frames.  This  general  sequence  of events 
was also experienced with  two epitopes expressed by hu- 
man  melanoma lines.  One  was shown  to  be partially  en- 
coded  in  an  intron,  for  which  expression  is  dependent 
upon aberrant splicing (17).  The second lies in an alternate 
reading frame of the gp75 gene (12). 
The recent report ofElliott et al. provides the first direct 
evidence for cryptic epitope expression  in vivo (13).  This 
study and ours are similar in that both employ expression of 
NP via a recombinant vac system although in their case the 
NP gene product is preceded by a leader sequence.  How- 
ever, results of the  two studies  are strikingly different.  EI- 
liott et at. observed strong presentation of NP36(,_374 in vitro 
and clear presentation in vivo even though the product was 
shifted to the  + 1 frame within codon 160. This frameshift 
is in  close proximity to our FS-D (also  a shift into the  + 1 
frame, at codon  151)  which had very limited in vitro anti- 
genicity.  We  did nor test the  FS-D  construct  in vivo but 
given  results  with  FS-B,  FS-C,  and  FS-E  we  expect  it 
would not stimulate a detectable response. The discrepancy 
may be due to the differing conditions of the in vitro assays 
used to detect expression of the epitope and to assess prim- 
ing in vivo. A more intriguing possibility is that translation 
coupled with translocation  (as would  occur with a leader- 
encoded  sequence)  is  more  susceptible  to  frameshifting. 
Indeed, the structure of the E. coti ribosome, as recently de- 
duced by low-dose cryoelectron microscopy (49,  50), sug- 
gests that there are two channels through which the polypep- 
tide  can  exit the  ribosome.  The  exit  of one  channel is  in 
the  membrane  associated domain  of the  50S  subunit  and 
may therefore be reserved for translocated  (secreted)  pro- 
teins.  It has been demonstrated that interactions of the na- 
scent peptide with the exit channel can influence decoding 
by inducing transient mRNA/peptidyl tRNA dissociation 
and stalling (51,  52). Assuming a similar arrangement exists 
for  eukaryotic  ribosomes,  perhaps  exit  through  the  exo- 
cytic channel induces a higher incidence of frameshifting as 
compared  with  exit  through  the  cytosolic  channel.  The 
mechanism underlying expression of an epitope in an alter- 
nate reading frame of the melanoma-associated gp75 gene 
(12)  has not yet been reported.  Its position within the pri- 
mary  open  reading  frame  (beginning  294  bases  from  the 
primary ATG) and the number of preceding ATG triplets 
(5) do not eliminate scanthrough as a possibility. However, 
this protein is  exocytic  (53,  54)  and  the  same mechanism 
operating in conjunction  with the  exocytic version of NP 
may also be at work here. 
Scanthrough translation may also have consequences for 
in-frame epitopes as well. We hypothesized that instability 
of the NP/32-498  product underlies presentation of FS-A 
and, further, that this product is a significant source of pro- 
cessing substrate in  the  expression of WT  NP.  However, 
presentation levels of the  NP147_is  5 epitope from the  NP/ 
M32I mutant were indistinguishable  from those associated 
with  WT  NP  (Fig.  8).  Additionally,  in  experiments  not 
shown, a BFA-mediated analysis demonstrated presentation 
of epitope  from  FS-A  to  be  significantly  lower than  that 
from wild-type NP.  Thus,  we  still  do  not  understand  the 
significance of the 1VI32  codon and do not yet have evidence 
that anything other than full-length NP provides the bulk 
of the  starting  processing  substrate  for  generation  of the 
epitopes in  our study.  However,  for other proteins  it re- 
mains possible that truncated  products generated by scan- 
through account for significant  quantities of epitope. Further, 
other mechanisms that would generate truncated products, 
such as premature termination, remain to be investigated. 
A  second extension of our findings involves the presen- 
tation of MHC class I epitopes derived from exocytic proteins. 
It has been generally assumed that the MHC class I-restricted 
presentation of these proteins is the result ofmis-transla- 
tion, resulting in the cytosolic proteolysis and processing of 
a fragment of these proteins that is not translocated into the 
endoplasmic reticulum  (ER)  (3,  37,  55).  More recently, it 
has  been  proposed  that  a  mammalian  equivalent  of the 
US 11  gene of cytomegalovirus (CMV)  may actively expel 
misformed membrane proteins from the ER. into the cyto- 
sol, whereupon they can be rapidly degraded (56).  In addi- 
tion  to  these  mechanisms,  we  wish  to propose that  ribo- 
somes  scanning  through  primary  initiation  codons  and 
initiating from downstream codons,  thereby bypassing the 
leader sequence required for ER translocation, may make a 
significant contribution  to the  substrate for processing and 
presentation ofexocytic proteins. 
The expression of cryptic epitopes could have an impor- 
tant  imnaunological impact and  physiological relevance in 
1327  Bullock and Eisenlohr areas such as thymic education, CTL mediated autoimmu- 
nity,  vaccine  design  and  cancer  immunotherapy.  Further 
investigations in this area should help elucidate the poten- 
tial influence of the inherent flexibility of translation in the 
development of immune responses. 
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